+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Marketing Authorization"

Global Orphan Drug Growth Opportunities - Product Thumbnail Image

Global Orphan Drug Growth Opportunities

  • Report
  • March 2024
  • 78 Pages
  • Global
From
From
From
Latest Trends in Orphan Drug Pricing and Reimbursement - Product Thumbnail Image

Latest Trends in Orphan Drug Pricing and Reimbursement

  • Report
  • February 2018
  • 135 Pages
  • Global
From
From
From
From
From
From
From
From
Loading Indicator

The Marketing Authorization market is a key component of the Drug Discovery process. It is the process of obtaining approval from regulatory authorities to market a drug or medical device. This process involves submitting a dossier of data to the relevant regulatory body, which is then reviewed to ensure the product meets safety and efficacy standards. The dossier includes pre-clinical and clinical data, manufacturing information, and other relevant information. The process also includes post-marketing surveillance to ensure the product continues to meet safety and efficacy standards. Companies in the Marketing Authorization market include AbbVie, AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more